David D O'Toole
CIK 1491140 · CFO · last filed 2026-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$861.9K
Companies
7
Total Filings
74
Lifetime Open-Market Net
$611.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCEL | CFO | 150,927 | $3.91 | $590.1K | $348.0K | 25 | 2026-06-01 |
| OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Chief Financial Officer | 0 | $20.65 | $0 | $113.7K | 24 | 2023-03-03 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | — | — | — | $0 | 1 | 2017-04-24 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | See Remarks | 44,750 | — | — | $94.4K | 12 | 2016-08-19 |
| CDXS | SVP & Chief Financial Officer | 110,687 | $2.40 | $265.6K | $45.1K | 6 | 2013-09-06 |
| MNOV | Director | 5,000 | $1.23 | $6.2K | $8.9K | 2 | 2012-05-30 |
| RESPONSE GENETICS INC (RGDX) Delisted | VP and Chief Financial Officer | 1,000 | — | — | $1.5K | 4 | 2012-02-06 |
Recent Filings · Page 5 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-15 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +1,100 | $16.4K | EDGAR |
| 2019-08-15 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +1,000 | $15.2K | EDGAR |
| 2019-08-13 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +1,000 | $15.5K | EDGAR |
| 2019-01-04 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-14 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +1,015 | $15.6K | EDGAR |
| 2018-05-16 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +2,000 | $33.9K | EDGAR |
| 2018-05-14 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Buy (P) | +3,000 | $56.6K | EDGAR |
| 2018-01-08 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-14 | OPIANT PHARMACEUTICALS, INC. (OPNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-24 | SOLENO THERAPEUTICS INC (CAPNW) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.